Delivery Order SPE2DB24D1021-SPE2DB25FESYU

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,169.70 firm fixed-price delivery order is for the supply of the pharmaceutical product TIVICAY 50 MG TABLET 30S. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This award is not designated under any set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,782.78 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,473.17 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 3, 2024. The $3,873.63 Firm Fixed Price Delivery Order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,744.24 Firm Fixed Price Delivery Order contract is for the delivery of TIVICAY 50 MG TABLET 30S, with a completion date of August 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560039203 TIVICAY 50 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order valued at $3,966.43, with a completion date of February 24, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,461.64 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of January 3, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $7,167.31 firm fixed price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,094.76 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 3, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,985.95 firm fixed-price delivery order is for the supply of TIVICAY 50 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESYU
    Delivery Order

This federal contract award, with ID SPE2DB24D1021|SPE2DB25FESYU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $19,780.35, to provide the pharmaceutical product TIVICAY 50 MG TABLET 30S.

The contract has an Ultimate Completion Date of January 9, 2025 and was awarded on January 8, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 4/9/25, 9:57 AM